Clinical Trial Update: Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing aspirin as a UV protectant in humans at risk for melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University of Utah | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED